Claim Ownership


Subscribed: 0Played: 0


In this podcast, our Medical Director, Brad Lewis, talks with Jamey Kain, Vice President of Genetic Innovation here at Machaon. Brad and Jamey discuss how we design our genetic panels, what goes in, what stays out and how we think about clinical utility and turnaround time considerations.Don't forget, Machaon offers genetic testing STAT results in 48 hours!
Join Dr. Kerstin de Wit and our Medical Director, Dr. Brad Lewis, discuss the importance of accessing and educating patients with newly diagnosed venous thrombotic disease. Many patient factors, including age, sex, activity and knowledge levels should be considered to optimize acceptance and disease management. Providers can help patients minimize distress with careful questioning and listening skills.
In this episode we hear an interview with Mike Ero, Machaon Diagnostics' Founder and CEO. A Clinical Laboratory Scientist (CLS) who added an MBA, Mike started Machaon Diagnostics back in 2003 at the age of 29. Just how did all of that come about? Listen and find out. We hope you find our origin story interesting. You'll get a good sense of why we were founded and the mission we are fulfilling today. 
Andra James, MD, MPH is a Professor of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine at Duke University Center, and consulting professor of Medicine, Division of Hematology. She is also the founder of Duke University's Women's Hemostasis and Thrombosis Clinic. Dr. James and Machaon Diagnostics' Medical Director, Dr. Brad Lewis, discuss the various approaches to monitoring bleeding disorders (VWD, Platelet Disorders and mild Hemophilia) during critical time frames before, during & after pregnancy in women.  Tracking factor levels and having a good plan in place for time of delivery is important. OB/GYNs and Hematologists can partner to provide the best care for patients at every step.
Our Medical Director, Brad Lewis, MD, discusses COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) and diagnostic strategies. 
In this episode Dr. Brad Lewis talks about PAI-1, testing for PAI-1 and where things look to be heading for the future of this gene and conditions associated with it.We released this episode to coincide with Pi Day (3.14).
Join Michelle Hermiston, MD, PhD - Associate Professor of Pediatrics (Pediatric Hematologist/Oncologist) at UCSF and our Medical Director, Brad Lewis, MD, discuss the challenges of diagnosing Hemophagocytic Lymphohistiocytosis or HLH, possible triggers and approach to management.If you are interested in our 48-hour STAT check out the link for more information 👉 We can send you draw kits and are happy to talk you through the process/details.
aHUS in Pregnancy

aHUS in Pregnancy


Our Medical Director, Brad Lewis, MD, discusses aHUS/TMAs in pregnancy with Richard Burwick, MD, MPH - Assistant Professor, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Cedars-Sinai Medical Center.If you are interested in our 48-hour STAT aHUS Testing please let us know. We can send you draw kits and are happy to talk you through the process/details.
Our Medical Director, Brad Lewis, addresses a number of questions around hypercoagulability and COVID-19.
Dr. Brad Lewis discusses sC5b-9 in this podcast addressing; what sC5b-9 testing is, why you want to know about this test and when to use it. Dr. Lewis also explores how it helps when trying to confirm a diagnosis. 
Dr. Brad Lewis discusses hemophagocytic lymphohistiocytosis (HLH); when you want to think about HLH, why you want to think about HLH, and how to diagnose this disorder. 
Dr. Lewis discusses TMAs in the post-BMT setting, recent research into the topic, when to think about it and what to do about it. 
Review of TMAs

Review of TMAs


Dr. Brad Lewis discusses considerations for genetic testing when it comes to hemophilia and rare forms of von Willebrand disease.
Download from Google Play
Download from App Store